SADS hosted a virtual EL-PFDD meeting with the U.S. FDA on Tuesday, June 20, 2023 to educate the FDA and other key stakeholders on the patient’s perspective about the challenges of living with ARVC/D with the limited therapies available today.
SADS hosted a virtual EL-PFDD meeting with the U.S. FDA on Tuesday, June 20, 2023 to educate the FDA and other key stakeholders on the patient’s perspective about the challenges of living with ARVC/D with the limited therapies available today.